Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 2 |
2019 | 1 |
2022 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial.
J Hematol Oncol. 2022 Aug 18;15(1):113. doi: 10.1186/s13045-022-01334-z.
J Hematol Oncol. 2022.
PMID: 35982483
Free PMC article.
Clinical Trial.
Correction: Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial.
Jiang Q, Li Z, Qin Y, Li W, Xu N, Liu B, Zhang Y, Meng L, Zhu H, Du X, Chen S, Liang Y, Hu Y, Liu X, Song Y, Men L, Chen Z, Niu Q, Wang H, Lu M, Yang D, Zhai Y, Huang X.
Jiang Q, et al.
J Hematol Oncol. 2023 Feb 20;16(1):13. doi: 10.1186/s13045-023-01414-8.
J Hematol Oncol. 2023.
PMID: 36803531
Free PMC article.
Clinical Trial.
No abstract available.
Item in Clipboard
Correction: Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial.
Jiang Q, Li Z, Qin Y, Li W, Xu N, Liu B, Zhang Y, Meng L, Zhu H, Du X, Chen S, Liang Y, Hu Y, Liu X, Song Y, Men L, Chen Z, Niu Q, Wang H, Lu M, Yang D, Zhai Y, Huang X.
Jiang Q, et al.
J Hematol Oncol. 2022 Oct 31;15(1):159. doi: 10.1186/s13045-022-01369-2.
J Hematol Oncol. 2022.
PMID: 36316695
Free PMC article.
No abstract available.
Item in Clipboard
Sodium arsenite exposure inhibits histone acetyltransferase p300 for attenuating H3K27ac at enhancers in mouse embryonic fibroblast cells.
Zhu Y, Li Y, Lou D, Gao Y, Yu J, Kong D, Zhang Q, Jia Y, Zhang H, Wang Z.
Zhu Y, et al.
Toxicol Appl Pharmacol. 2018 Oct 15;357:70-79. doi: 10.1016/j.taap.2018.08.011. Epub 2018 Aug 18.
Toxicol Appl Pharmacol. 2018.
PMID: 30130555
Free PMC article.
Item in Clipboard
Validation of the TadpoleTM Campylobacter jejuni Real-Time PCR Identification Kit.
Jiang Y, Shen J, Xue F, Zhao L, Yang J, Shao J, Zhu C, Su J, Chen Y, Brodsky M, Salfinger Y.
Jiang Y, et al.
J AOAC Int. 2019 May 1;102(3):842-854. doi: 10.5740/jaoacint.18-0323. Epub 2018 Nov 19.
J AOAC Int. 2019.
PMID: 30454080
Item in Clipboard
Cite
Cite